We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Zacks Analyst Blog Highlights S&P Global, Honeywell International, Elevance Health and Sypris Solutions
Read MoreHide Full Article
For Immediate Release
Chicago, IL – July 24, 2024 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: S&P Global Inc. (SPGI - Free Report) , Honeywell International Inc. (HON - Free Report) , Elevance Health, Inc. (ELV - Free Report) and Sypris Solutions, Inc. (SYPR - Free Report) .
Here are highlights from Tuesday’s Analyst Blog:
Q2 Earnings Scorecard and Today's Analyst Reports for SPGI, HON, ELV & More
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features a real-time update on the Q2 earnings season and new research reports on 16 major stocks, including S&P Global Inc., Honeywell International Inc. and Elevance Health, Inc., as well a micro-cap stock Sypris Solutions, Inc.. The Zacks microcap research is unique as our research content on these small and under-the-radar companies is the only research of its type in the country.
These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
Including this morning's releases from Coke, UPS, GM and others, we now have Q2 results from 103 S&P 500 members or 20.6% of the index's total membership. Total earnings for these companies are up +6.8% from the same period last year on +3.5% higher revenues, with 82.5% beating EPS estimates and 59.2% beating revenue estimates.
Comparing the Q2 results from these companies relative to what we had seen from the same group of 103 companies in other recent periods, we find
- The Q2 EPS beats percentage of 82.5% compares to 79.6% in each of the preceding two periods and the average for the preceding 20-quarters (5 years) of 79.8%.
- The Q2 revenue beats percentage of 59.2% compares to 66% and 68% for this group of 103 index members in 2024 Q1 and 2023 Q4, respectively. The 20-quarter average for this group of companies is 70.6%. This means that companies continue to struggle to beat revenue estimates.
- With respect to the growth rates, the earnings growth rate of +6.8% for this group of 103 companies is up from +6.3% in 2024 Q1, -0.7% in 2023 Q4, +2.5% in 2023 Q3, +0.4% in 2023 Q2 and so on. In other words, an accelerating growth trend on the earnings front.
- With respect to revenues, the Q2 revenue growth rate of +3.5% is down from +4% in 2024 Q1, +3.1% in 2023 Q4, +4.5% in 2023 Q3 and so on.
Looking at Q2 as a whole, combining the actuals that have come out with estimates for the still-to-come companies, total earnings are expected to be up +9.2% from the same period last year on +4.9% higher revenues, which will be the highest earnings growth pace since the +10% earnings growth rate in 2022 Q1.
Today's Featured Analyst Reports
S&P Global shares have outperformed the Zacks Business - Information Services industry over the past year (+15.3% vs. +12.8%). The company remains well-poised to gain from the growing demand for business information services. Buyouts help innovate, increase differentiated content and develop new products.
New service launches have been aiding the company's growth. Dividend payments and share buybacks boost investors' confidence and positively impact earnings per share.
However, S&P Global remains vulnerable to proceedings, investigations and inquiries concerning the ratings provided, leading to legal charges, damages or fines. Growth initiatives, higher compensations and incentives raise the company's expenses.
Shares of Honeywell have outperformed the Zacks Diversified Operations industry over the year-to-date period (+3.3% vs. -4.4%). The company's strength in the commercial aviation, building automation and UOP businesses augurs well. The Aerospace segment is particularly strong, driven by robust demand in the aviation aftermarket.
A strong commercial aftermarket and solid commercial aviation demand, led by strength in the air transport aftermarket, are aiding the Aerospace segment. Handsome rewards to shareholders add to the stock's appeal. The ability to generate strong free cash flow supports its shareholder-friendly activities.
The company's commercial and operational excellence initiatives, along with its pricing actions, enable it to maintain a healthy margin performance. While acquisitions have expanded its product range and geographic reach, they have increased Honeywell's balance sheet debt as well. Foreign currency translation remains an overhang.
Elevance Health shares have outperformed the Zacks Medical Services industry over the past year (+7.0% vs. +2.0%). The company beat earnings estimates by 1.3% in the second quarter. Its revenue growth, fueled by premium rate increases and rising memberships, contributes to its positive trajectory.
Strategic acquisitions and partnerships have fortified its business portfolio. A robust Medicare Advantage segment, combined with successful contract acquisitions, is poised to drive future memberships. It reaffirmed the 2024 earnings guidance to $37.20 per share. The Carelon business is a key contributor to its success. ELV utilizes excess capital to boost shareholder value.
However, its rising expenses continue to put pressure on margins. Its high balance sheet debt is reducing financial flexibility. Also, its declining free cash flow is a concern. As such, the stock warrants a cautious stance.
Shares of Sypris Solutions have outperformed the Zacks Electronics - Miscellaneous Services industry over the past year (+3.8% vs. -8.8%). This microcap company with market capitalization of $42.81 million has secured a long-term, sole-source contract extension with a major commercial vehicle manufacturer for Ultra Axle Shafts, ensuring stable revenues and reinforcing its industry reputation.
Sypris Solutions' Sypris Electronics unit is also expanding in the electronic warfare market with additional U.S. Navy contracts, enhancing defense capabilities against threats. Sypris' strong position in the growing aerospace and defense electronics markets supports sustained revenue growth. Financial stability is bolstered by an improved cash balance. A significant backlog provides revenue visibility and supports financial planning.
However, the company faces challenges with net losses widening to $2.2 million in Q1 2024 and reduced profit margins. Rising operating expenses, high debt levels and competitive pressures also pose risks.
Since 2000, our top stock-picking strategies have blown away the S&P's +7.0 average gain per year. Amazingly, they soared with average gains of +44.9%, +48.4% and +55.2% per year.
Today you can access their live picks without cost or obligation.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
The Zacks Analyst Blog Highlights S&P Global, Honeywell International, Elevance Health and Sypris Solutions
For Immediate Release
Chicago, IL – July 24, 2024 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: S&P Global Inc. (SPGI - Free Report) , Honeywell International Inc. (HON - Free Report) , Elevance Health, Inc. (ELV - Free Report) and Sypris Solutions, Inc. (SYPR - Free Report) .
Here are highlights from Tuesday’s Analyst Blog:
Q2 Earnings Scorecard and Today's Analyst Reports for SPGI, HON, ELV & More
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features a real-time update on the Q2 earnings season and new research reports on 16 major stocks, including S&P Global Inc., Honeywell International Inc. and Elevance Health, Inc., as well a micro-cap stock Sypris Solutions, Inc.. The Zacks microcap research is unique as our research content on these small and under-the-radar companies is the only research of its type in the country.
These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today's research reports here >>>
Q2 Earnings Season Scorecard
Including this morning's releases from Coke, UPS, GM and others, we now have Q2 results from 103 S&P 500 members or 20.6% of the index's total membership. Total earnings for these companies are up +6.8% from the same period last year on +3.5% higher revenues, with 82.5% beating EPS estimates and 59.2% beating revenue estimates.
Comparing the Q2 results from these companies relative to what we had seen from the same group of 103 companies in other recent periods, we find
- The Q2 EPS beats percentage of 82.5% compares to 79.6% in each of the preceding two periods and the average for the preceding 20-quarters (5 years) of 79.8%.
- The Q2 revenue beats percentage of 59.2% compares to 66% and 68% for this group of 103 index members in 2024 Q1 and 2023 Q4, respectively. The 20-quarter average for this group of companies is 70.6%. This means that companies continue to struggle to beat revenue estimates.
- With respect to the growth rates, the earnings growth rate of +6.8% for this group of 103 companies is up from +6.3% in 2024 Q1, -0.7% in 2023 Q4, +2.5% in 2023 Q3, +0.4% in 2023 Q2 and so on. In other words, an accelerating growth trend on the earnings front.
- With respect to revenues, the Q2 revenue growth rate of +3.5% is down from +4% in 2024 Q1, +3.1% in 2023 Q4, +4.5% in 2023 Q3 and so on.
Looking at Q2 as a whole, combining the actuals that have come out with estimates for the still-to-come companies, total earnings are expected to be up +9.2% from the same period last year on +4.9% higher revenues, which will be the highest earnings growth pace since the +10% earnings growth rate in 2022 Q1.
Today's Featured Analyst Reports
S&P Global shares have outperformed the Zacks Business - Information Services industry over the past year (+15.3% vs. +12.8%). The company remains well-poised to gain from the growing demand for business information services. Buyouts help innovate, increase differentiated content and develop new products.
New service launches have been aiding the company's growth. Dividend payments and share buybacks boost investors' confidence and positively impact earnings per share.
However, S&P Global remains vulnerable to proceedings, investigations and inquiries concerning the ratings provided, leading to legal charges, damages or fines. Growth initiatives, higher compensations and incentives raise the company's expenses.
(You can read the full research report on S&P Global here >>>)
Shares of Honeywell have outperformed the Zacks Diversified Operations industry over the year-to-date period (+3.3% vs. -4.4%). The company's strength in the commercial aviation, building automation and UOP businesses augurs well. The Aerospace segment is particularly strong, driven by robust demand in the aviation aftermarket.
A strong commercial aftermarket and solid commercial aviation demand, led by strength in the air transport aftermarket, are aiding the Aerospace segment. Handsome rewards to shareholders add to the stock's appeal. The ability to generate strong free cash flow supports its shareholder-friendly activities.
The company's commercial and operational excellence initiatives, along with its pricing actions, enable it to maintain a healthy margin performance. While acquisitions have expanded its product range and geographic reach, they have increased Honeywell's balance sheet debt as well. Foreign currency translation remains an overhang.
(You can read the full research report on Honeywell here >>>)
Elevance Health shares have outperformed the Zacks Medical Services industry over the past year (+7.0% vs. +2.0%). The company beat earnings estimates by 1.3% in the second quarter. Its revenue growth, fueled by premium rate increases and rising memberships, contributes to its positive trajectory.
Strategic acquisitions and partnerships have fortified its business portfolio. A robust Medicare Advantage segment, combined with successful contract acquisitions, is poised to drive future memberships. It reaffirmed the 2024 earnings guidance to $37.20 per share. The Carelon business is a key contributor to its success. ELV utilizes excess capital to boost shareholder value.
However, its rising expenses continue to put pressure on margins. Its high balance sheet debt is reducing financial flexibility. Also, its declining free cash flow is a concern. As such, the stock warrants a cautious stance.
(You can read the full research report on Elevance Health here >>>)
Shares of Sypris Solutions have outperformed the Zacks Electronics - Miscellaneous Services industry over the past year (+3.8% vs. -8.8%). This microcap company with market capitalization of $42.81 million has secured a long-term, sole-source contract extension with a major commercial vehicle manufacturer for Ultra Axle Shafts, ensuring stable revenues and reinforcing its industry reputation.
Sypris Solutions' Sypris Electronics unit is also expanding in the electronic warfare market with additional U.S. Navy contracts, enhancing defense capabilities against threats. Sypris' strong position in the growing aerospace and defense electronics markets supports sustained revenue growth. Financial stability is bolstered by an improved cash balance. A significant backlog provides revenue visibility and supports financial planning.
However, the company faces challenges with net losses widening to $2.2 million in Q1 2024 and reduced profit margins. Rising operating expenses, high debt levels and competitive pressures also pose risks.
(You can read the full research report on Sypris Solutions here >>>)
Why Haven't You Looked at Zacks' Top Stocks?
Since 2000, our top stock-picking strategies have blown away the S&P's +7.0 average gain per year. Amazingly, they soared with average gains of +44.9%, +48.4% and +55.2% per year.
Today you can access their live picks without cost or obligation.
See Stocks Free >>
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.